EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Risk, BMI Status, BMI Change Patterns, and the Risk of Steatotic Liver Disease and Liver Enzyme Elevation in Chinese Adults

Juan Yang iD, Chan Tian, Maojie Liu, Haiyan Guo, Fei Lin, Yang Ding, Wentao Yao, Jiahao Zhang, Jingyi Fan, Chengxiao Yu iD, Jing Lu, Qun Zhang

Nutrients · 2024

DOI: 10.3390/nu16234212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Juan Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Alanine Transaminase, Body Mass Index, Genetic Predisposition to Disease, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Capability Improvement Project through Science, Technology and Education, Jiangsu Medical Association Medical Research Project of Health Management.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Whether an increased genetic risk of steatotic liver disease (SLD) can be offset by maintaining a healthy weight remains unknown. We aimed to clarify the associations among the body mass index (BMI) and its change patterns with SLD and assess whether genetic susceptibility can modify these associations in Chinese people.

Methods

A total of 10,091 and 6124 participants from the Health Omics Preventive Examination (HOPE) Program were enrolled in cross-sectional and follow-up analyses, respectively. BMI change patterns were defined according to the BMI at baseline and the last follow-up visit. Genetic risk was estimated using the polygenic risk score (PRS) derived from variants in PNPLA3, TM6SF2, MBOAT7, and GCKR. Data were analyzed using logistic regression models and Cox proportional-hazards models.

Results

The analyses of the BMI and genetic risk simultaneously showed a dose–response association with the risk of SLD (p-trend < 0.001). Significant interactions between BMI and PRS were found for alanine aminotransferase (ALT) elevation (p = 0.007) and aspartate aminotransferase (AST) elevation (p < 0.001). Weight loss led to a 71%, 60%, and 67% lower risk of SLD, ALT elevation, and AST elevation, compared with stable overweight/obesity. A significant interaction between the genetic risk and BMI change patterns in ALT elevation was observed (p = 0.008). The absolute risk reductions associated with weight loss were greater for participants at a high genetic risk (26.60, 12.29, and 9.31 per 100 person years for SLD, ALT elevation, and AST elevation, respectively).

Conclusions

Maintaining a healthy weight reduces the liver injury risk among all individuals, and the risk reduction is greater among the subset with a high genetic risk of SLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alanine TransaminaseBody Mass IndexGenetic Predisposition to DiseaseNon-alcoholic Fatty Liver DiseaseAdultFemaleHumansMaleMiddle AgedAdaptor Proteins, Signal TransducingAspartate AminotransferasesChinaCross-Sectional StudiesEast Asian PeopleFatty LiverLipaseLiverMembrane ProteinsObesityPhospholipases A2, Calcium-IndependentRisk FactorsWeight LossAcyltransferases

Stichwörter der Autor:innen

BMI change patterngenetic susceptibilityliver enzyme elevationsteatotic liver disease

Substanzen

Adaptor Proteins, Signal TransducingAlanine TransaminaseAspartate AminotransferasesLipaseMembrane ProteinsPhospholipases A2, Calcium-IndependentGCKR protein, humanMBOAT7 protein, humanAcyltransferasesPNPLA3 protein, human

Autor:innen und Institutionen

  • Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
  • Health Management Center, Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou 234099, China.
  • Health Management Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

ORCID-Profile: Juan Yang, Chengxiao Yu

Förderung

  • Jiangsu Province Capability Improvement Project through Science, Technology and Education
  • Jiangsu Medical Association Medical Research Project of Health Management

Zitieren

APA

Yang, J., Tian, C., Liu, M., Guo, H., Lin, F., Ding, Y., Yao, W., Zhang, J., Fan, J., Yu, C., Lu, J., & Zhang, Q. (2024). Genetic Risk, BMI Status, BMI Change Patterns, and the Risk of Steatotic Liver Disease and Liver Enzyme Elevation in Chinese Adults. Nutrients. https://doi.org/10.3390/nu16234212

Vancouver

Yang J, Tian C, Liu M, Guo H, Lin F, Ding Y, et al. Genetic Risk, BMI Status, BMI Change Patterns, and the Risk of Steatotic Liver Disease and Liver Enzyme Elevation in Chinese Adults. Nutrients. 2024. doi:10.3390/nu16234212

BibTeX
@article{Yang2024,
  author = {Yang, Juan and Tian, Chan and Liu, Maojie and Guo, Haiyan and Lin, Fei and Ding, Yang and Yao, Wentao and Zhang, Jiahao and Fan, Jingyi and Yu, Chengxiao and Lu, Jing and Zhang, Qun},
  title = {Genetic Risk, BMI Status, BMI Change Patterns, and the Risk of Steatotic Liver Disease and Liver Enzyme Elevation in Chinese Adults},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16234212}
}
Kostenlos starten →